Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

EVOLVE-1 trial assesses mTOR inhibitor plus best supportive care in hepatocellular carcinoma

Sep. 7, 2011

Merck & Co. reports discovery of new tachykinin NK1 receptor antagonists

Sep. 7, 2011

Doxazosin versus tizanidine assessed in children with voiding dysfunction

Sep. 7, 2011

SHIFT substudy evaluates ivabradine in patients on background therapy for heart failure

Sep. 7, 2011

Yokukansan ameliorates aspects of two autism spectrum disorders

Sep. 7, 2011

Esmirtazapine may impair day-after driving performance

Sep. 7, 2011

Lu-AA-21004 prevents relapse of major depression in long-term trial

Sep. 6, 2011

Methylene blue beneficial as adjunctive therapy for bipolar disorder

Sep. 6, 2011

Eisai divulges additional phase III data on proprietary AMPA-type glutamate receptor antagonist

Sep. 6, 2011

Data disclosed from ARISTOTLE trial of apixaban vs. warfarin in atrial fibrillation

Sep. 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...